Semler Scientific, Inc., headquartered in Santa Clara, California, offers technology and software solutions to enhance healthcare clinical effectiveness, focusing on chronic diseases with products like QuantaFlo for PAD diagnosis. The company, which employs 127 people and went public in 2014, also distributes Insulin Insights in the U.S. for managing Type 2 diabetes.
SMLR has been in the news recently: Semler Scientific, Inc. has purchased 581 bitcoins for $40 million as its primary treasury reserve asset, leading to a 30% surge in their stock price. The company believes in the value and potential for outsize returns of bitcoin, following the lead of MicroStrategy.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
